Literature DB >> 31502264

Review article: impact of exercise on physical frailty in patients with chronic liver disease.

Felicity R Williams1,2, Annalisa Berzigotti3, Janet M Lord1,4, Jennifer C Lai5, Matthew J Armstrong1,2.   

Abstract

BACKGROUND: Physical frailty is common in chronic liver disease and the setting of liver transplantation. It is associated with poor quality of life, increased hospitalisation and mortality. Despite this, the impact of exercise in these patients remains poorly understood. AIM: To summarise the impact of physical exercise on physical frailty in patients with chronic liver disease until after liver transplantation.
METHODS: A MEDLINE and PubMed search was undertaken using the terms; "physical activity", "functional capacity", "exercise", "prehabilitation", "frailty", "liver cirrhosis", "liver failure", "liver transplantation" "chronic liver disease" and "end-stage liver disease" from January 1990 to June 2019.
RESULTS: Eleven studies (five randomised controlled, five observational, one case study) demonstrated that exercise improves VO2 peak, anaerobic threshold, 6-minute walk distance, muscle mass/function and quality of life in patients with compensated and decompensated cirrhosis. Improvements were most significant with a combination of aerobic and resistance exercises at moderate-high intensity. The studies were small (n = 1-50) and mainly focused on supervised, hospital-based exercises, excluding patients with significant liver failure (MELD > 12). Seven studies (four randomised controlled and three observational) demonstrated that predominantly supervised (only one home-based) aerobic exercise after liver transplantation improves aerobic capacity, muscle mass/strength and quality of life. There was marked heterogeneity in timing, intensity and type of exercises.
CONCLUSION: Exercise improves key components of physical frailty (functional/aerobic capacity, sarcopenia) and quality of life in chronic liver disease and after liver transplantation. Understanding the type, compliance, intensity and duration of exercise and its impact on hard clinical outcomes should be the focus of future large controlled clinical trials.
© 2019 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2019        PMID: 31502264     DOI: 10.1111/apt.15491

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  20 in total

Review 1.  Sarcopenia in chronic liver disease: mechanisms and countermeasures.

Authors:  Sophie L Allen; Jonathan I Quinlan; Amritpal Dhaliwal; Matthew J Armstrong; Ahmed M Elsharkawy; Carolyn A Greig; Janet M Lord; Gareth G Lavery; Leigh Breen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-11-25       Impact factor: 4.052

2.  A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis.

Authors:  Surender Singh; Sunil Taneja; Puneeta Tandon; Akash Bansal; Ujjwal Gorsi; Akash Roy; Arka De; Nipun Verma; Madhumita Premkumar; Ajay Duseja; Radha K Dhiman; Virendra Singh
Journal:  J Clin Exp Hepatol       Date:  2021-07-21

3.  Assessment of frailty in cirrhosis using bedside measures and its correlation with Child-Turcotte-Pugh, MELD & MELD-Na Scores.

Authors:  Bader Faiyaz Zuberi; Tazeen Rasheed; Faiza Sadaqat Ali; Nimrah Bader; Rabia Sadaf
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

Review 4.  Sarcopenia in cirrhosis: A practical overview.

Authors:  Amritpal Dhaliwal; Matthew J Armstrong
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

5.  Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

6.  Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

7.  A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).

Authors:  Jennifer C Lai; Jennifer L Dodge; Matthew R Kappus; Randi Wong; Yara Mohamad; Dorry L Segev; Mara McAdams-DeMarco
Journal:  Am J Gastroenterol       Date:  2021-04       Impact factor: 10.864

Review 8.  Sarcopenia and Frailty in Liver Cirrhosis.

Authors:  Hiroki Nishikawa; Shinya Fukunishi; Akira Asai; Shuhei Nishiguchi; Kazuhide Higuchi
Journal:  Life (Basel)       Date:  2021-04-27

9.  Karnofsky performance status predicts outcomes in candidates for simultaneous liver-kidney transplant.

Authors:  Hani Shamseddeen; Francis Pike; Marwan Ghabril; Kavish R Patidar; Archita P Desai; Lauren Nephew; Melissa Anderson; Chandrashekhar Kubal; Naga Chalasani; Eric S Orman
Journal:  Clin Transplant       Date:  2020-12-29       Impact factor: 3.456

10.  Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jennifer C Lai; Puneeta Tandon; William Bernal; Elliot B Tapper; Udeme Ekong; Srinivasan Dasarathy; Elizabeth J Carey
Journal:  Hepatology       Date:  2021-09       Impact factor: 17.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.